{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T18:21:35Z","timestamp":1758219695852,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00520-025-09872-1","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T03:30:03Z","timestamp":1756179003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of end-of-Life chemotherapy: a medical and economic challenge revealed by a retrospective observational study"],"prefix":"10.1007","volume":"33","author":[{"given":"Paul","family":"Agius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-4763","authenticated-orcid":false,"given":"Sophie","family":"L\u00e9obon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00eblle","family":"Maillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8474-3116","authenticated-orcid":false,"given":"\u00c9lise","family":"Deluche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"9872_CR1","unstructured":"Institut Nationale du cancer (2022) Panorama des cancers en France, \u00e9dition 2022. https:\/\/www.cancerenvironnement.fr\/app\/uploads\/2023\/06\/INCa-2022_Panorama-des-cancers-en-France_Edition2022.pdf"},{"key":"9872_CR2","unstructured":"Plan national (2021\u20132024) D\u00e9veloppement des Soins Palliatifs et Accompagnement de la fin de vie. https:\/\/sante.gouv.fr\/IMG\/pdf\/plan-fin-de-vie-2022.pdf"},{"issue":"1","key":"9872_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12904-022-01075-3","volume":"21","author":"J Lee","year":"2022","unstructured":"Lee J, Shafiq M, Malhotra R, Ozdemir S, Teo I, Malhotra C (2022) Trajectories of health-related quality of life in patients with advanced cancer during the last year of life: findings from the COMPASS study. BMC Palliat Care 21(1):183. https:\/\/doi.org\/10.1186\/s12904-022-01075-3","journal-title":"BMC Palliat Care"},{"issue":"1","key":"9872_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12904-022-00927-2","volume":"21","author":"MG Oosterveld-Vlug","year":"2022","unstructured":"Oosterveld-Vlug MG, Heins MJ, Boddaert MSA, Engels Y, Heide AV, Onwuteaka-Philipsen BD, Reyners AKL, Francke AL (2022) Evaluating quality of care at the end of life and setting best practice performance standards: a population-based observational study using linked routinely collected administrative databases. BMC Palliat Care 21(1):51. https:\/\/doi.org\/10.1186\/s12904-022-00927-2","journal-title":"BMC Palliat Care"},{"issue":"1","key":"9872_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1049909107307376","volume":"25","author":"M Miyashita","year":"2008","unstructured":"Miyashita M, Nakamura A, Morita T, Bito S (2008) Identification of quality indicators of end-of-life cancer care from medical chart review using a modified delphi method in Japan. Am J Hosp Palliat Care 25(1):33\u201338. https:\/\/doi.org\/10.1177\/1049909107307376","journal-title":"Am J Hosp Palliat Care"},{"issue":"3","key":"9872_CR6","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1200\/JOP.2015.004416","volume":"11","author":"L Barbera","year":"2015","unstructured":"Barbera L, Seow H, Sutradhar R, Chu A, Burge F, Fassbender K, McGrail K, Lawson B, Liu Y, Pataky R, Potapov A (2015) Quality indicators of end-of-life care in patients with cancer: what rate is right? J Oncol Pract 11(3):e279\u2013e287. https:\/\/doi.org\/10.1200\/JOP.2015.004416","journal-title":"J Oncol Pract"},{"key":"9872_CR7","doi-asserted-by":"crossref","unstructured":"Barbera L, Paszat L, Chartier C (2006)\u00a0 Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 22(1):12\u20137","DOI":"10.1177\/082585970602200103"},{"issue":"3","key":"9872_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/jpm.2011.0393","volume":"15","author":"N Raijmakers","year":"2012","unstructured":"Raijmakers N, Galushko M, Domeisen F, Beccaro M, Lundh Hagelin C, Lindqvist O, Popa-Velea O, Romotzky V, Schuler S, Ellershaw J, Ostgathe C, OPCARE9 (2012) Quality indicators for care of cancer patients in their last days of life: literature update and experts\u2019 evaluation. J Palliat Med 15(3):308\u2013316. https:\/\/doi.org\/10.1089\/jpm.2011.0393","journal-title":"J Palliat Med"},{"issue":"6","key":"9872_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","volume":"21","author":"CC Earle","year":"2003","unstructured":"Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21(6):1133\u20131138. https:\/\/doi.org\/10.1200\/JCO.2003.03.059","journal-title":"J Clin Oncol"},{"issue":"2","key":"9872_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1200\/JCO.2004.08.136","volume":"22","author":"CC Earle","year":"2004","unstructured":"Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22(2):315\u2013321. https:\/\/doi.org\/10.1200\/JCO.2004.08.136","journal-title":"J Clin Oncol"},{"key":"9872_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.12688\/f1000research.27121.1","volume":"9","author":"S Budhwani","year":"2020","unstructured":"Budhwani S, Gill A, Scott M et al (2020) Measuring indicators of health system performance for palliative and end-of-life care using health administrative data: a scoping review. F1000Res 9:1438. https:\/\/doi.org\/10.12688\/f1000research.27121.1","journal-title":"F1000Res"},{"issue":"4","key":"9872_CR12","doi-asserted-by":"publisher","first-page":"100225","DOI":"10.1016\/j.esmoop.2021.100225","volume":"6","author":"GB Crawford","year":"2021","unstructured":"Crawford GB, Dzier\u017canowski T, Hauser K, Larkin P, Luque-Blanco AI, Murphy I, Puchalski CM, Ripamonti CI, ESMO Guidelines Committee (2021) Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines. ESMO Open 6(4):100225. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100225","journal-title":"ESMO Open"},{"issue":"19","key":"9872_CR13","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1200\/JCO.24.00542","volume":"42","author":"JJ Sanders","year":"2024","unstructured":"Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF, Epstein AS, Firn JI, Jones JA, Litzow MR, Lundquist D, Mardones MA, Nipp RD, Rabow MW, Rosa WE, Zimmermann C, Ferrell BR (2024Jul) Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol 42(19):2336\u20132357. https:\/\/doi.org\/10.1200\/JCO.24.00542","journal-title":"J Clin Oncol"},{"issue":"1","key":"9872_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12904-019-0419-4","volume":"18","author":"I Colombet","year":"2019","unstructured":"Colombet I, Bouleuc C, Piolot A, Vilfaillot A, Jaulmes H, Voisin-Saltiel S, Goldwasser F, Vinant P, EFIQUAVIE study group (2019) Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation. BMC Palliat Care 18(1):35. https:\/\/doi.org\/10.1186\/s12904-019-0419-4","journal-title":"BMC Palliat Care"},{"issue":"5","key":"9872_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jpainsymman.2015.12.323","volume":"51","author":"MM Garrido","year":"2016","unstructured":"Garrido MM, Prigerson HG, Bao Y, Maciejewski PK (2016May) Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life. J Pain Symptom Manage 51(5):875-881.e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.323","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"9872_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jpainsymman.2017.12.335","volume":"55","author":"Y Bao","year":"2018","unstructured":"Bao Y, Maciejewski RC, Garrido MM, Shah MA, Maciejewski PK, Prigerson HG (2018Apr) Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer. J Pain Symptom Manage 55(4):1113-1121.e3. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.12.335","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"9872_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10120-015-0486-z","volume":"19","author":"LM Hess","year":"2016","unstructured":"Hess LM, Michael D, Mytelka DS, Beyrer J, Liepa AM, Nicol S (2016) Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data. Gastric Cancer 19(2):607\u2013615. https:\/\/doi.org\/10.1007\/s10120-015-0486-z","journal-title":"Gastric Cancer"},{"issue":"6","key":"9872_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3111\/13696998.2012.713414","volume":"15","author":"E Laas","year":"2012","unstructured":"Laas E, Vataire AL, Aballea S, Valentine W, Gligorov J, Chereau E, Rouzier R (2012) Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France. J Med Econ 15(6):1167\u20131175. https:\/\/doi.org\/10.3111\/13696998.2012.713414","journal-title":"J Med Econ"},{"key":"9872_CR19","unstructured":"AFSOS (2016) Quand associer une approche palliative sp\u00e9cialis\u00e9e pour les patients adultes atteints de cancer?\u00a0https:\/\/www.afsos.org\/wp-content\/uploads\/2016\/12\/Orientation-_SP_AFSOS_SFAP.pdf"},{"issue":"21","key":"9872_CR20","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","volume":"24","author":"R Matsuyama","year":"2006","unstructured":"Matsuyama R, Reddy S, Smith TJ (2006Jul) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24(21):3490\u20133496. https:\/\/doi.org\/10.1200\/JCO.2005.03.6236","journal-title":"J Clin Oncol"},{"issue":"4","key":"9872_CR21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00520-015-2959-3","volume":"24","author":"T Assi","year":"2016","unstructured":"Assi T, El Rassy E, Tabchi S, Ibrahim T, Moussa T, Chebib R, El Karak F, Farhat F, Chahine G, Nasr F, Ghosn M, Kattan J (2016) Treatment of cancer patients in their last month of life: aimless chemotherapy. Support Care Cancer 24(4):1603\u20131608. https:\/\/doi.org\/10.1007\/s00520-015-2959-3","journal-title":"Support Care Cancer"},{"issue":"4","key":"9872_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/annonc\/mdw654","volume":"28","author":"P Rochigneux","year":"2017","unstructured":"Rochigneux P, Raoul JL, Beaussant Y, Aubry R, Goldwasser F, Tournigand C, Morin L (2017) Use of chemotherapy near the end of life: what factors matter? Ann Oncol 28(4):809\u2013817. https:\/\/doi.org\/10.1093\/annonc\/mdw654","journal-title":"Ann Oncol"},{"issue":"9","key":"9872_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/annonc\/mdp027","volume":"20","author":"S Kao","year":"2009","unstructured":"Kao S, Shafiq J, Vardy J, Adams D (2009) Use of chemotherapy at end of life in oncology patients. Ann Oncol 20(9):1555\u20131559","journal-title":"Ann Oncol"},{"key":"9872_CR24","doi-asserted-by":"crossref","unstructured":"Bekelman JE, Halpern SD, Blankart CR et al (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. 315(3):272.16","DOI":"10.1001\/jama.2015.18603"},{"issue":"11","key":"9872_CR25","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/annonc\/mdr416","volume":"22","author":"S Braga","year":"2011","unstructured":"Braga S (2011) Why do our patients get chemotherapy until the end of life? Ann Oncol 22(11):2345\u20132348","journal-title":"Ann Oncol"},{"issue":"11","key":"9872_CR26","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/jjco\/hyab145","volume":"51","author":"S Shirane","year":"2021","unstructured":"Shirane S, Michihata N, Yoshiuchi K, Ariyoshi K, Iwase S, Morita K, Matsui H, Fushimi K, Yasunaga H (2021) Evaluation of quality indicators near death in older adult cancer decedents in Japan: a nationwide retrospective cohort study. Jpn J Clin Oncol 51(11):1643\u20131648. https:\/\/doi.org\/10.1093\/jjco\/hyab145","journal-title":"Jpn J Clin Oncol"},{"issue":"23","key":"9872_CR27","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","volume":"26","author":"CC Earle","year":"2008","unstructured":"Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26(23):3860\u20133866. https:\/\/doi.org\/10.1200\/JCO.2007.15.8253","journal-title":"J Clin Oncol"},{"key":"9872_CR28","doi-asserted-by":"publisher","unstructured":"Fuhrman C, Mandereau-Bruno L (2016) Multimorbidit\u00e9, un indicateur de surveillance \u00e9pid\u00e9miologique.\u00a0Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique 4970(1004):S167\u2013S266. https:\/\/doi.org\/10.1016\/j.respe.2016.06.251","DOI":"10.1016\/j.respe.2016.06.251"},{"key":"9872_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1684\/ito.2019.0178","volume":"5","author":"H Bourgeois","year":"2019","unstructured":"Bourgeois H, Jestin-Le Tallec V, De Decker L, Dupuis O, Voog E, Ganem G, Juhel-Voog L, Capitain O, Delva R, Souli\u00e9 P, Abadie-Lacourtoisie S, Gu\u00e9rin-Meyer V, Morin-Meschin ME, Bourbouloux E, Kaassis M, Edeline J, Delecroix V, Egreteau J, Ferec M, Artignan X, Loisel I, Gentric A, Berrut G, D\u00e9niel-Lagadec D, Marhuenda F, Ingrand P, Grud\u00e9 F (2019) Validation du score Pronopall chez des patients oncog\u00e9riatriques en situation palliative. Innov Ther Oncol 5:267\u2013274. https:\/\/doi.org\/10.1684\/ito.2019.0178","journal-title":"Innov Ther Oncol"},{"key":"9872_CR30","unstructured":"Habert-Dantigny R (2020) \u00c9tat des lieux national des connaissances et de l\u2019utilisation des \u00e9chelles pronostiques par les m\u00e9decins exer\u00e7ant en oncologie et en soins palliatifs, chez des patients adultes atteints d\u2019un cancer en phase palliative avanc\u00e9e. M\u00e9decine humaine et pathologie. dumas-03371274. Dissertation, Grenoble university, France. https:\/\/dumas.ccsd.cnrs.fr\/dumas-03371274v1\/file\/2020GRAL5126_habert-dantigny_raphaelle_dif.pdf"},{"issue":"15","key":"9872_CR31","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1200\/JCO.2007.14.9518","volume":"26","author":"AC Barbot","year":"2008","unstructured":"Barbot AC, Mussault P, Ingrand P, Tourani JM (2008) Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J Clin Oncol 26(15):2538\u20132543. https:\/\/doi.org\/10.1200\/JCO.2007.14.9518","journal-title":"J Clin Oncol"},{"key":"9872_CR32","unstructured":"Lallier JC (2019) Score PRONOPALL. https:\/\/jclallier.site\/pronopall"},{"key":"9872_CR33","unstructured":"World Health Organization (2017) Medication without harm: world health organization.\u00a0https:\/\/iris.who.int\/bitstream\/handle\/10665\/255263\/WHO-HIS-SDS-2017.6-eng.pdf"},{"issue":"1","key":"9872_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12904-022-00910-x","volume":"21","author":"I Woldie","year":"2022","unstructured":"Woldie I, Elfiki T, Kulkarni S, Springer C, McArthur E, Freeman N (2022) Chemotherapy during the last 30 days of life and the role of palliative care referral, a single center experience. BMC Palliat Care 21(1):20. https:\/\/doi.org\/10.1186\/s12904-022-00910-x","journal-title":"BMC Palliat Care"},{"issue":"5","key":"9872_CR35","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.21037\/apm-20-273","volume":"9","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen ML, Gu XL, Cheng WW (2020) Use of palliative chemotherapy near the end of life: a retrospective cohort study. Ann Palliat Med 9(5):2809\u20132816. https:\/\/doi.org\/10.21037\/apm-20-273","journal-title":"Ann Palliat Med"},{"issue":"4","key":"9872_CR36","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1177\/10781552211006180","volume":"28","author":"CL McDermott","year":"2022","unstructured":"McDermott CL, Curtis JR, Sun Q, Fedorenko C, Kreizenbeck K, Ramsey SD (2022Jun) Cy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer. J Oncol Pharm Pract 28(4):836\u2013841. https:\/\/doi.org\/10.1177\/10781552211006180","journal-title":"J Oncol Pharm Pract"},{"key":"9872_CR37","doi-asserted-by":"publisher","unstructured":"Santos P\u00e9rez MI, Godoy D\u00edez M, Abajo Del \u00c1lamo C (2019) Quimioterapia al final de la vida: \u00bfpr\u00e1ctica cl\u00ednica poco frecuente? [Chemotherapy at the end of life: Uncommon clinical practice?]. J Healthc Qual Res 34(4):201\u2013207. Spanish. https:\/\/doi.org\/10.1016\/j.jhqr.2019.04.002","DOI":"10.1016\/j.jhqr.2019.04.002"},{"issue":"5","key":"9872_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/030089160709300502","volume":"93","author":"AA Martoni","year":"2007","unstructured":"Martoni AA, Tanneberger S, Mutri V (2007) Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori 93(5):417\u2013422. https:\/\/doi.org\/10.1177\/030089160709300502","journal-title":"Tumori"},{"issue":"5","key":"9872_CR39","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.clinre.2021.101709","volume":"45","author":"A Lapeyre-Prost","year":"2021","unstructured":"Lapeyre-Prost A, Perkins G, Vallee M, Pozet A, Tougeron D, Maillet M, Locher C, Dreanic J, Legoux JL, Li\u00e8vre A, Lecaille C, Sabate JM, Mary F, Bonnetain F, Jaulmes-Bouillot H, Behal F, Landi B, Taieb J (2021) Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study. Clin Res Hepatol Gastroenterol 45(5):101709. https:\/\/doi.org\/10.1016\/j.clinre.2021.101709","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3\u20134","key":"9872_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000112802","volume":"72","author":"YH Yun","year":"2007","unstructured":"Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, Lee CG, Choi YS, Hong YS, Kim SY, Heo DS (2007) Chemotherapy use and associated factors among cancer patients near the end of life. Oncology 72(3\u20134):164\u2013171. https:\/\/doi.org\/10.1159\/000112802","journal-title":"Oncology"},{"issue":"7408","key":"9872_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","volume":"327","author":"P Glare","year":"2003","unstructured":"Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003Jul 26) A systematic review of physicians\u2019 survival predictions in terminally ill cancer patients. BMJ 327(7408):195\u2013198. https:\/\/doi.org\/10.1136\/bmj.327.7408.195","journal-title":"BMJ"},{"issue":"1","key":"9872_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/10499091221098062","volume":"40","author":"MP Davis","year":"2023","unstructured":"Davis MP, Vanenkevort EA, Elder A, Young A, Correa Ordonez ID, Wojtowicz MJ, Ellison H, Fernandez C, Mehta Z, Behm B, Digwood G, Panikkar R (2023) The financial impact of palliative care and aggressive cancer care on end-of-life health care costs. Am J Hosp Palliat Care 40(1):52\u201360. https:\/\/doi.org\/10.1177\/10499091221098062","journal-title":"Am J Hosp Palliat Care"},{"key":"9872_CR43","unstructured":"AFSOS (2018) Chimioth\u00e9rapie et cancer en phase palliative avanc\u00e9e [Internet]. https:\/\/www.afsos.org\/wp-content\/uploads\/2014\/12\/Chimioth%C3%A9rapie-et-cancer_phase-palliative-avanc%C3%A9e_AFSOS.pdf. Accessed 11 Mar 2018"},{"issue":"3","key":"9872_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40273-023-01336-w","volume":"42","author":"AH Perea-Bello","year":"2024","unstructured":"Perea-Bello AH, Trapero-Bertran M, D\u00fcrsteler C (2024) Palliative care costs in different ambulatory-based settings: a systematic review. Pharmacoeconomics 42(3):301\u2013318. https:\/\/doi.org\/10.1007\/s40273-023-01336-w","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"9872_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1200\/OP.23.00576","volume":"21","author":"S Lu","year":"2025","unstructured":"Lu S, Rakovitch E, Hannon B, Zimmermann C, Dharmarajan KV, Yan M, De Almeida JR, Yao CMKL, Gillespie EF, Chino F, Yerramilli D, Goonaratne E, Abdel-Rahman F, Othman H, Mheid S, Tsai CJ (2025Feb) Palliative care as a component of high-value and cost-saving care during hospitalization for metastatic cancer. JCO Oncol Pract 21(2):252\u2013260. https:\/\/doi.org\/10.1200\/OP.23.00576","journal-title":"JCO Oncol Pract"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09872-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:03:31Z","timestamp":1758164611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9872"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09872-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical data were collected in accordance with French bioethics laws regarding patient information and consent. The Limoges Hospital Ethics Committee approved the study protocol (President, Dr Terrier; approval number 494\u20132021-150).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"808"}}